Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2026-01-25 @ 7:07 AM
Study NCT ID:
NCT05973968
Status:
UNKNOWN
Last Update Posted:
2023-08-04
First Post:
2023-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Surufatinib in G3 Neuroendocrine Tumors
Sponsor:
Qilu Hospital of Shandong University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
KYLL-202210-028-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None